Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor M Rivera

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Journal of Neuroimmunology|June 30, 2004
Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosisJian Hong, Ying C Q Zang, George Hutton, et al.
Oncotarget|September 12, 2015
Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitorsTheresa Baker, Sujata Nerle, Justin Pritchard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2003
Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse modelJulie Johnston, John Tazelaar, Victor M Rivera, et al.
International Journal of Oncology|May 23, 2012
Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer modelsRachel M Squillace, David Miller, Scott D Wardwell, et al.
Journal of Neuroimmunology|April 18, 2002
Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa BYing C Q Zang, Jyotsnabaran B Halder, Jian Hong, et al.
Annals of Neurology|January 31, 2003
Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosisMaria V Tejada-Simon, Ying C Q Zang, Jian Hong, et al.
Oncotarget|April 7, 2016
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and miceJoachim T Siaw, Haiying Wan, Kathrin Pfeifer, et al.
Cancer Chemotherapy and Pharmacology|January 11, 2012
Analysis of the pharmacodynamic activity of the mTOR inhibitor ridaforolimus (AP23573, MK-8669) in a phase 1 clinical trialLori Berk, Monica M Mita, Jeff Kreisberg, et al.
International Journal of MS Care|January 24, 2014
The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosisJose Avila-Ornelas, Mirla Avila, Milena Stosic, et al.
Journal of Virology|May 22, 2002
Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controlsMaria V Tejada-Simon, Ying C Q Zang, Jian Hong, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Journal of Neuroimmunology|June 30, 2004
Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosisJian Hong, Ying C Q Zang, George Hutton, et al.
Oncotarget|September 12, 2015
Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitorsTheresa Baker, Sujata Nerle, Justin Pritchard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2003
Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse modelJulie Johnston, John Tazelaar, Victor M Rivera, et al.
International Journal of Oncology|May 23, 2012
Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer modelsRachel M Squillace, David Miller, Scott D Wardwell, et al.
Journal of Neuroimmunology|April 18, 2002
Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa BYing C Q Zang, Jyotsnabaran B Halder, Jian Hong, et al.
Annals of Neurology|January 31, 2003
Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosisMaria V Tejada-Simon, Ying C Q Zang, Jian Hong, et al.
Oncotarget|April 7, 2016
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and miceJoachim T Siaw, Haiying Wan, Kathrin Pfeifer, et al.
Cancer Chemotherapy and Pharmacology|January 11, 2012
Analysis of the pharmacodynamic activity of the mTOR inhibitor ridaforolimus (AP23573, MK-8669) in a phase 1 clinical trialLori Berk, Monica M Mita, Jeff Kreisberg, et al.
International Journal of MS Care|January 24, 2014
The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosisJose Avila-Ornelas, Mirla Avila, Milena Stosic, et al.
Journal of Virology|May 22, 2002
Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controlsMaria V Tejada-Simon, Ying C Q Zang, Jian Hong, et al.
Pageof 10